BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6335629)

  • 21. [Reaction to dinitrochlorobenzene in patients on regular dialysis and after kidney transplantation].
    Volfová Z; Jirka J; Tschernoster E; Rossmann P; Zástava V
    Vnitr Lek; 1986 Jan; 32(1):40-7. PubMed ID: 3513439
    [No Abstract]   [Full Text] [Related]  

  • 22. A new predictive factor for the outcome of renal transplantation.
    Diamondopoulos AA; Hamilton DN; Briggs JD
    Proc Eur Dial Transplant Assoc; 1978; 15():283-8. PubMed ID: 368775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on immunological skin reactions in patients with active pulmonary tuberculosis. Clinical significance of the reduction of DNCB reaction in patients with active pulmonary tuberculosis].
    Ishibashi J
    Kekkaku; 1982 Dec; 57(12):665-70. PubMed ID: 7182645
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cellular immunity in protein-caloric malnutrition].
    Khadraoui S; Lopez V; Hamza B; Smith NJ
    Arch Fr Pediatr; 1977 Feb; 34(2):143-53. PubMed ID: 405954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Skin reactivity to dinitrochlorobenzene (DNCB) in long-term mycotic infections].
    Matusiewicz R
    Przegl Lek; 1983; 40(5):435-7. PubMed ID: 6622743
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man.
    Miller AE; Levis WR
    J Clin Invest; 1973 Aug; 52(8):1925-30. PubMed ID: 4719669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular immunity in children with viral hepatitis as based on DNCB skin tests].
    Debski R
    Pediatr Pol; 1978 Jun; 53(6):707-14. PubMed ID: 693126
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative dinitrochlorobenzene contact sensitization in a normal population.
    Catalona WJ; Taylor PT; Chretien PB
    Clin Exp Immunol; 1972 Nov; 12(3):325-33. PubMed ID: 4642908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitiligo and DNCB sensitization in achromic skin].
    Haji-Abrassi M; Samsoen M; Grosshans E
    Ann Dermatol Venereol; 1981; 108(12):1023-5. PubMed ID: 7337368
    [No Abstract]   [Full Text] [Related]  

  • 30. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
    Ruszel KB
    Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
    [No Abstract]   [Full Text] [Related]  

  • 31. Dinitrochlorobenzene skin test reactivity as a predictor of outcome in transplantation of juvenile onset diabetics.
    Maxwell JG; Lawrence PF; Warden GD
    Transplantation; 1981 Nov; 32(5):381-4. PubMed ID: 7036453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of cellular immunity by dinitrochlorobenzene skin test].
    Matild H
    Orv Hetil; 1975 Sep; 116(39):2291-3. PubMed ID: 1187110
    [No Abstract]   [Full Text] [Related]  

  • 33. [The DNCB test in pneumology].
    Polistina D
    Arch Monaldi; 1977; 32(3):15-8. PubMed ID: 616268
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative DNCB epicutaneous sensitization in leprosy patients and controls.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1981 Jan; 53(1):45-51. PubMed ID: 7218763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of the skin reaction to DNCB and to PHA during a course of acute viral HBs Ag positive and negative hepatitis and in carriers of HBs Ag].
    Lanzalene CM; D'Amate C; Cirelli A
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1638-41. PubMed ID: 1230164
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of tolerance to DNCB-contact sensitivity induced by immunosuppressive agents.
    Polak L; Rinck C
    Allergol Immunopathol (Madr); 1978; 6(1):39-44. PubMed ID: 308299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of correlation between skin reactivity to dinitrochlorobenzene and croton oil in patients with cancer.
    Roth JA; Eilber FR; Nizze JA; Morton DL
    N Engl J Med; 1975 Aug; 293(8):388-9. PubMed ID: 1152937
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS; Jogaikar DG; Mehta JM
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanism of cell-mediated immunodeficiency in chronic renal failure.
    Shahin MH; Afifi N; El Sheemy N; Mohamed AA; Barsoum RS
    J Egypt Med Assoc; 1977; 60(5-6):385-95. PubMed ID: 314949
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva.
    Ferry AP; Meltzer MA; Taub RN
    Trans Am Ophthalmol Soc; 1976; 74():154-71. PubMed ID: 325854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.